Standardisation of a coproantigen reduction test (CRT) protocol for the diagnosis of resistance to triclabendazole in Fasciola hepatica

  • A.M. Flanagan
  • , H.W.J. Edgar
  • , F. Forster
  • , A. Gordon
  • , Ronnie Hanna
  • , M. McCoy
  • , Gerard Brennan
  • , Ian Fairweather

Research output: Contribution to journalArticlepeer-review

66 Citations (Scopus)

Abstract

A sheep trial was performed to standardise a coproantigen reduction test (CRT) protocol for the diagnosis of resistance to triclabendazole (TCBZ) in Fasciola hepatica). The CRT employs the BIO K201 Fasciola coproantigen ELISA (Bio-X Diagnostics, Jemelle, Belgium) to test for the presence of F. hepatica coproantigens in a faecal sample. If it is coproantigen-positive, the CRT protocol recommends that faecal samples are re-tested for coproantigens at 14 days post-treatment (dpt), with negative testing at this point indicating TCBZ success.
Original languageEnglish
Pages (from-to)34-42
Number of pages9
JournalVeterinary Parasitology
Volume176
Issue number1
DOIs
Publication statusPublished - 28 Feb 2011

ASJC Scopus subject areas

  • Parasitology
  • General Veterinary

Fingerprint

Dive into the research topics of 'Standardisation of a coproantigen reduction test (CRT) protocol for the diagnosis of resistance to triclabendazole in Fasciola hepatica'. Together they form a unique fingerprint.

Cite this